NEW YORK, July 18, 2024 /PRNewswire/ -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or breaches of fiduciary duties to shareholders relating to:Berenson Acquisition Corp. I (NYSE American: BACA)'s merger with Custom Health Inc. Under the proposed transaction, Custom Health will combine with Berenson and become a publicly-listed entity trading on the NYSE under its existing name. The proposed transaction i ...

Table of Contents Title of each classTrading Symbol(s)Name of each exchange on which registered UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K (Mark One) ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2023 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number: 001-40843 Berenson Acquisition Corp. I ( ...

Financial Position - As of September 30, 2023, the Trust Account held cash and marketable securities amounting to approximately $11.36 million[120]. - A total of $275.1 million was placed in the Trust Account following the Initial Public Offering and Private Placement, with transaction costs amounting to $15.64 million[118]. - The company has no long-term debt obligations or off-balance sheet arrangements as of September 30, 2023[126][127]. Income and Expenses - For the nine months ended September 30, 2023, the company reported a net income of $2.10 million, influenced by interest income of $3.59 million and a change in fair value of derivative warrant liabilities of $742,490[116]. - The company incurred operating costs of $1.51 million for the nine months ended September 30, 2023[116]. - The company has incurred a monthly fee of $10,000 to the Sponsor for office space and administrative support since September 28, 2021[127]. Stockholder Actions - On September 27, 2023, stockholders approved an extension for the company to consummate a Business Combination until September 30, 2024[112]. - The company had 4,045,468 shares of Class A common stock issued and outstanding as of September 30, 2023[113]. - The company redeemed approximately 1.54 million shares of Class A common stock for a total of $16.07 million at a redemption price of approximately $10.40 per share[113]. Stock and Warrant Accounting - The company accounts for common stock subject to possible redemption in accordance with ASC 480, classifying it outside of permanent equity due to redemption provisions not solely within its control[131]. - All Class A common stock sold in the Initial Public Offering includes a redemption feature, allowing for redemption in connection with liquidation events, stockholder votes, or tender offers[132]. - Changes in the redemption value of redeemable shares are recognized immediately, with adjustments affecting additional paid-in capital and accumulated deficit[132]. - Public and private placement warrants are recorded as liabilities under ASC Topic 815-40, as they do not meet equity classification criteria[134]. - As of September 30, 2023, private placement warrants were no longer classified as Level 3 inputs due to the availability of a quoted price for a similar instrument[134]. - The estimated fair value of public warrants is determined by their public trading price, while private placement warrants are valued using a modified Black-Scholes model[134]. Use of Funds - The company plans to use funds in the Trust Account primarily to complete its initial Business Combination and for working capital of the target business[120].

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (MARK ONE) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended: June 30, 2023 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to | --- | --- | |-----------------------------------------------------------------------------------------------------|-------------------- ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (MARK ONE) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended: March 31, 2023 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to | --- | --- | |---------------------------------------------------------------------------------------------------------------------|--------------------- ...

Table of Contents Title of each classTrading Symbol(s)Name of each exchange on which registered Class A common stock, par value $0.0001 per share BACA NYSE American LLC UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K (Mark One) ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2022 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period ...